BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05815485-completion@plaintrial.com
DTSTAMP:20261028T082131Z
DTSTART;VALUE=DATE:202604
SUMMARY:A Randomized\, Double-Blind\, Placebo-Controlled Phase 2/3 Study to
  Determine the Safety and Effectiveness of Azeliragon in the Treatment of 
 Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia
  — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05815485
URL:https://plaintrial.com/trial/NCT05815485
END:VEVENT
END:VCALENDAR